16 completed, 5 unknown, 3 terminated, 2 recruiting. 29 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 29 | Completed 16, Unknown 5, Terminated 3, Recruiting 2, Not yet recruiting 1, Suspended 1, Withdrawn 1 |
Follow Cancer Pain: new trials by email Literature Review of Cancer Pain trials Research Report on Cancer Pain
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Real World Study of Oxycodone/Naloxone Sustained-Release Tablets (Mimeixin) for Patients With Severe Cancer Pain Oxycodone Hydrochloride and Naloxone Hydrochloride Sustained-release Tablets - Opioid-Induced Constipation, Pain Cancer | Phase 4 | Not yet recruiting | Henan Cancer Hospital | 203 | 2025-04-01 | 2025-03-27 |
| Determining the Effect of Abiraterone on the Metabolism of Oxycodone in Men With Prostate Cancer (the ENABLE Study) Oxycodone oral capsule 15 mg, Abiraterone Acetate Tablets 500 mg - Prostate Cancer, Pain Cancer | Phase 4 | Recruiting | Deventer Ziekenhuis | 29 | 2024-04-12 | 2025-06-03 |
| Optimizing Subcutaneous FEntanyl titRation: RApid Achievement of Adequate Exposure When Treating Cancer-Related paIn. Fentanyl - Cancer Pain | Phase 4 | Unknown | Erasmus Medical Center | 45 | 2024-02-23 | 2024-07-12 |
| Prevention of Opioid-induced Constipation in Patients With Advanced Cancer Macrogol Only Product in Oral Dose Form, Magnesium hydroxide 724mg - Constipation, Opioid-Induced | Phase 4 | Recruiting | Amsterdam UMC, location VUmc | 258 | 2022-12-02 | 2026-10-05 |
| Buprenorphine for Cancer Pain Use of buprenorphine with FAO > 30 OME, CPM Rx application use - Cancer-Related Pain | Phase 4 | Unknown | Fox Chase Cancer Center | 50 | 2022-08-10 | 2023-07-10 |
| Endoscopic Ultrasound Guided Coeliac Plexus Neurolysis for Cancer Pain Alcohol injection, Radiofrequency Ablation - Malignancy, Pain Management | Phase 4 | Unknown | The University of Hong Kong | 54 | 2021-03-01 | 2021-03-22 |
| EUS-Coeliac Plexus Block Versus Radiofrequency Ablation in Pain Relief of Patients With Malignancy 98% dehydrated alcohol, 19G EUSRA needle, Taewoong Medical, Korea - Cancer of Pancreas, Pancreatic Neoplasms | Phase 4 | Unknown | The University of Hong Kong | 54 | 2020-09-21 | 2021-03-22 |
| Permanent Celiac Plexus Block: Comparison of Pain Score in Unilateral and Bilateral Posterior Percutaneous Approach Unilateral Neurolytic Celiac Plexus Block with Absolute Alcohol, Bilateral Neurolytic Celiac Plexus Block with Absolute Alcohol - Abdominal Cancer, Cancer Pain | Phase 4 | Completed | Sindh Institute of Urology and Transplantation | 30 | 2020-02-25 | 2024-03-19 |
| Usefulness of Acetaminophen Associated With Strong Opioids for Acute Pain in Cancer Patients Acetaminophen, Placebo - Acute Pain, Cancer Pain | Phase 4 | Completed | Pontificia Universidad Catolica de Chile | 112 | 2019-06-10 | 2021-08-13 |
| Change the Dose Frequency of Controlled-Release Oxycodone to Refractory Pain Increasing the Controlled-Release Oxycodone dose frequency - Cancer Pains | Phase 4 | Withdrawn | Fujian Cancer Hospital | 2018-10-30 | 2021-03-08 | |
| Study Evaluating Safety and Tolerability of Oxycodone in Patients With Moderate to Severe Cancer Pain Oxycodone - Cancer, Pain | Phase 4 | Completed | Taiwan Mundipharma Pharmaceuticals Ltd. | 73 | 2016-10-31 | 2020-03-18 |
| A Study to Compare the Titration Efficacy and Safety of Control-released Oxycodone and Immediate-released Oxycodone in Patients With Moderate to Severe Cancer Pain Oxycodone - Cancer, Pain | Phase 4 | Completed | Taiwan Mundipharma Pharmaceuticals Ltd. | 30 | 2016-09-01 | 2020-03-18 |
| An Interventional Study for Patient With Cancer Pain to Evaluate the Efficacy and Safety of OxyNorm® Compared to Morphine Sulfate Through the IV Continuous Infusion. Oxycodone Hydrochloride, Morphine Sulphate - Cancer Pain | Phase 4 | Completed | Mundipharma Korea Ltd | 66 | 2015-11-01 | 2018-11-19 |
| PROspective Non-interventional Open laBEl Trial for TARGIN in Korean Patients With Cancer Pain Oxycodone/Naloxone - Cancer | Phase 4 | Completed | Mundipharma Korea Ltd | 359 | 2012-07-01 | 2016-08-19 |
| Study to Evaluate Effectiveness and Tolerability of OROS Hydromorphone for Cancer Pain Treatment in Korean Patients OROS hydromorphone - Cancer Pain | Phase 4 | Completed | Janssen Korea, Ltd., Korea | 106 | 2011-12-01 | 2013-09-06 |
| Development and Evaluation of a Methadone Protocol for Severe Chronic Pain Management Methadone - Pain, Chronic | Phase 4 | Completed | Mahidol University | 34 | 2011-07-01 | 2015-01-09 |
| A Study to Evaluate Efficacy and Safety of Oxycodone/Naloxone Compared to OxyContin in Korean Cancer Patients Oxycodone/Naloxone, Oxycodone(single compound) - Cancer | Phase 4 | Completed | Mundipharma Korea Ltd | 128 | 2011-05-01 | 2017-12-22 |
| RCT Comparing the Analgesic Efficacy of 4 Therapeutic Strategies Based on 4 Different Major Opioids (Fentanyl, Oxycodone, Buprenorphine vs Morphine) in Cancer Patients With Moderate/Severe Pain, at the Moment of Starting 3rd Step of WHO Analgesic Ladder. Morphine, Fentanyl, Buprenorphine - Cancer, Cancer Pain | Phase 4 | Completed | Mario Negri Institute for Pharmacological Research | 518 | 2011-04-01 | 2015-12-24 |
| Paracetamol for Cancer Pain paracetamol, placebo tablets - Advanced Cancer, Opioid Use, Unspecified | Phase 4 | Unknown | Haraldsplass Deaconess Hospital | 50 | 2011-04-01 | 2011-03-11 |
| The Effect of Cancer Pain Management Protocol on Hospitalized Cancer Patients: A Pilot Study Cancer pain management - Cancers, Pain | Phase 4 | Completed | National Cancer Center, Korea | 25 | 2010-01-01 | 2012-04-27 |
Showing 20 of 29. Sign in to see all of them.
Neoplasms (9) · Pain (8) · Agnosia (3) · Breakthrough Pain (2) · Chronic Pain (2) · Opioid-Induced Constipation (2) · Pancreatic Neoplasms (2) · Acute Pain (1) · Adenomatous Polyposis Coli (1) · Dizziness (1) · Nausea (1) · Osteoarthritis (1) · Pain, Intractable (1) · Prostatic Neoplasms (1)
Neurologic Manifestations (29) · Pathological Conditions, Signs and Symptoms (29) · Signs and Symptoms (29) · Pain (21) · Neoplasms (4) · Neoplasms by Site (4) · Digestive System Diseases (3) · Digestive System Neoplasms (3) · Nervous System Diseases (3) · Neurobehavioral Manifestations (3) · Perceptual Disorders (3) · Signs and Symptoms, Digestive (3) · Chemically-Induced Disorders (2) · Constipation (2) · Endocrine Gland Neoplasms (2)
Oxycodone (9) · Fentanyl (5) · Ethanol (3) · Morphine (3) · Acetaminophen (2) · Buprenorphine (2) · Naloxone (2) · Abiraterone Acetate (1) · Dosage Forms (1) · Duration of Therapy (1) · Electrolytes (1) · Hydromorphone (1) · Magnesium Hydroxide (1) · Methadone (1) · Polyethylene Glycols (1)
Janssen Korea, Ltd., Korea (3) · Mundipharma Korea Ltd (3) · Taiwan Mundipharma Pharmaceuticals Ltd. (2) · The University of Hong Kong (2) · Amsterdam UMC, location VUmc (1) · Cephalon (1) · Deventer Ziekenhuis (1) · Erasmus Medical Center (1) · Fondazione IRCCS Policlinico San Matteo di Pavia (1) · Fox Chase Cancer Center (1) · Fujian Cancer Hospital (1) · Haraldsplass Deaconess Hospital (1) · Henan Cancer Hospital (1) · Janssen Cilag S.A.S. (1) · Janssen-Cilag Ltd. (1)
South Korea (5) · Italy (3) · Netherlands (3) · Hong Kong (2) · Taiwan (2) · United Kingdom (2) · Chile (1) · China (1) · France (1) · Germany (1) · Ireland (1) · Norway (1) · Pakistan (1) · Poland (1) · Spain (1)
Ka Wing Ma, MBBS, MS (2) · Chih-Jen Hung, MSc (1) · Chuthamanee Suthisisang, Ph.D. (1) · Dae Hyun Kim, Prof (1) · Jan Henrik Rosland, MD, PhD (1) · Jinhyong Kang, Dr. Ph.D (1) · Kang Jugnhoon (1)
PMID 10813730, PMID 11013380, PMID 11033377, PMID 11068116, PMID 11331334, PMID 14694929, PMID 15310785, PMID 15813511, PMID 16869819, PMID 17509812, PMID 17916403, PMID 18843665, PMID 19343373, PMID 19421788, PMID 20083373, PMID 20332509, PMID 22126843, PMID 22300860, PMID 22952129, PMID 23354635, PMID 24595069, PMID 24760709, PMID 24799466, PMID 24799483, PMID 24799495, PMID 25530283, PMID 25761441, PMID 26059846, PMID 26940689, PMID 27839957, PMID 28276273, PMID 28323080, PMID 28700092, PMID 28893309, PMID 29220110, PMID 29670416, PMID 30776210, PMID 35794673, PMID 36915062, PMID 37207788, PMID 41948194, PMID 7500538, PMID 9848918
2023 (2), 2008 (1)